FineTest
SKU(재고 관리 코드):FNab00618
anti- ASAH1 antibody
anti- ASAH1 antibody
Embark on a journey into the world of lipid metabolism and lysosomal storage disorders with our Anti-ASAH1 Antibody, available in a convenient 100µg size. ASAH1, a critical enzyme involved in ceramide catabolism, plays a pivotal role in maintaining lipid homeostasis and is associated with diseases such as Niemann-Pick disease.
This highly specific antibody offers exceptional sensitivity and specificity, ensuring accurate and reproducible results in applications such as immunohistochemistry and enzyme assays. Whether you're investigating ASAH1's functions in lysosomal function, its role in lipid storage diseases, or its implications in therapeutic interventions, our antibody is your dependable research partner.
The 100µg size provides cost-effective versatility, accommodating both small-scale experiments and larger research initiatives. Its consistent quality and purity make it an ideal choice for researchers across diverse disciplines, from molecular biology to medicine.
Choose our Anti-ASAH1 Antibody to propel your research forward and gain fresh insights into the complex world of lysosomal disorders and ceramide metabolism. Count on its performance, specificity, and reliability to drive your scientific discovery forward and contribute to the body of knowledge in your field.
Product Name
ASAH1 antibody
Size
100µg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Host
Rabbit
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
BACKGROUND
Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid.
IMMUNOGEN INFORMATION
Immunogen
N-acylsphingosine amidohydrolase(acid ceramidase) 1
Synonyms
ASAH
Observed MW
44-60 kDa
APPLICATION
Tested Application
ELISA, IHC, IF, WB, IP
Recommended Dilution
WB: 1:500-1:2000; IF: 1:10-1:100 ; IHC: 1:20-1:200; IP: 1:500-1:1000
UNIPROT INFORMATION
UniProt ID
IMAGES



Share
